A Study to Assess the Effect of a Single Infusion of VAY736 on Disease Activity in Patients With Relapsing-remitting Multiple Sclerosis

NCT02038049 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
8
Enrollment
INDUSTRY
Sponsor class

Stopped The study recruitment was terminated based on strategic considerations after 8 patients were enrolled.

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals